Guizhou Sanli Pharmaceutical Co.,Ltd (SHA:603439)
China · Delayed Price · Currency is CNY 11.98
+0.08 (0.67%)
Feb 4, 2026, 3:00 PM CST
SHA:603439 Market Cap
SHA:603439 has a market cap or net worth of 4.82 billion as of February 3, 2026. Its market cap has decreased by -6.75% in one year.
Market Cap
4.82B
Enterprise Value
5.37B
Revenue
1.74B
Ranking
n/a
PE Ratio
29.78
Stock Price
11.98
Market Cap Chart
Since April 28, 2020, SHA:603439's market cap has increased from 4.31B to 4.82B, an increase of 11.76%. That is a compound annual growth rate of 1.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 3, 2026 | 4.82B | 1.71% |
| Dec 31, 2025 | 4.74B | -9.02% |
| Dec 31, 2024 | 5.20B | -32.74% |
| Dec 29, 2023 | 7.74B | 37.27% |
| Dec 30, 2022 | 5.64B | -13.05% |
| Dec 31, 2021 | 6.48B | -21.44% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Apr 28, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Newland Pharmaceutical | 4.97B |
| Shanghai Jiaoda Onlly Co.,Ltd | 4.92B |
| Tibet Duo Rui Pharmaceutical | 4.91B |
| Jinhe Biotechnology CO., LTD. | 4.90B |
| Shanghai Xiao Fang Pharmaceutical | 4.86B |
| Shandong Sinobioway Biomedicine | 4.86B |
| Zhuhai Rundu Pharmaceutical | 4.82B |
| Tibet Weixinkang Medicine | 4.82B |